Worth reading
27Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
4
LocationWording
Conditional
How definitive the wording is.This transaction
Business acquisition comprising four dispensing pharmaciesCounterparty株式会社セカンドセブン, 株式会社サードセブン
Disclosing companyCREATE SD HOLDINGS CO.,LTD.
TimelineThe spacing between the points is proportional to the actual number of days.
Target company
Medical-mall-format dispensing pharmacies
Location Yokohama, Yokosuka and Yamato, Kanagawa Prefecture
Impact on Business Performance
The Company considers the impact of this transaction on its results to be immaterial.
| Item | Details |
|---|---|
| Transaction name | Business acquisition comprising four dispensing pharmacies |
| Counterparty name | 株式会社セカンドセブン, 株式会社サードセブン |
| Business Description of the Subject Company | Medical-mall-format dispensing pharmacies |
| Location of the Subject Company | Yokohama, Yokosuka and Yamato, Kanagawa Prefecture |
| Impact on Business Performance | The Company considers the impact of this transaction on its results to be immaterial. |
| Date of board resolution | 19 October 2026 |
| Contract Date | 19 October 2026 |
| Execution Date / Effective Date | 1 February 2027 (scheduled) |
Items this document does not state (24)
Name of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Valuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company determined that incorporating four highly accessible and specialized dispensing pharmacies located within its dominant area would create synergies with its existing businesses and enhance corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.